Redefining Musculoskeletal Care
Musculoskeletal conditions affect over 100 million patients and cost approximately $661 billion annually, representing 8% of payers' medical expenditures. Current MSK care approaches are fragmented and overly reliant on imaging, opioids, and surgical interventions, leading to poor patient outcomes and financial strain. High-value care requires evidence-based, holistic treatment that meets patient needs without unnecessary resources, emphasizing physical therapy, lifestyle modifications, and digital health solutions. The healthcare industry must address misaligned payment incentives and traditional utilization management strategies that create barriers to delivering coordinated, cost-effective care.
In this guide, you'll explore
- Over 100 million patients received MSK care in 2023, costing $661 billion annually
- 77% of patients in pain prefer non-surgical treatment options over surgery
- Digital health tools and multidisciplinary approaches prevent surgery in 95% of MSK patients who complete treatment
- Misaligned fee-for-service payment incentives encourage procedural volumes over appropriate care
- Traditional utilization management strategies like prior authorization create administrative burden and care delays